Veerhealth Care Ltd Stock Price Today (NSE: VEERHEALTH)
Fundamental Score
Veerhealth Care Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Veerhealth Care Ltd share price today is ₹19.09, up +0.00% on NSE/BSE as of 17 February 2026. Veerhealth Care Ltd (VEERHEALTH) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹38.28 (Cr). The 52-week high for VEERHEALTH share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 83.22x, VEERHEALTH is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 1.77% and a debt-to-equity ratio of 0.20.
Veerhealth Care Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Veerhealth Care Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Veerhealth Care Share Price: A Financial Stability Analysis
The pharmaceutical industry, known for its high research and development costs and lengthy regulatory approval processes, demands robust financial health from its players. This analysis focuses on the financial stability of Veerhealth Care Ltd, considering the latest stock data and performance relative to its peers. Currently, the Veerhealth Care share price stands at ₹17.690000534057617, with a Price-to-Earnings (PE) ratio of 83.22 and a Return on Capital Employed (ROCE) of 3.14%. This analysis is part of an 80-parameter fundamental audit, verified by Sweta Mishra.
The elevated PE ratio of 83.22 suggests that the market has high expectations for Veerhealth Care's future earnings growth. However, this must be viewed in the context of its ROCE. A ROCE of 3.14% indicates a relatively low return on invested capital. This comparatively low ROCE impacts the company's moat, or competitive advantage. A stronger ROCE would suggest a more robust ability to generate profits from its existing assets, making it harder for competitors to erode its market share. The current ROCE suggests limited reinvestment opportunities without impacting shareholder value.
Comparing Veerhealth Care with its peers provides further context.
Mankind Pharma Ltd, for example, often demonstrates a strong management track record evidenced by efficient capital allocation and consistent growth strategies. A comparison of management quality and strategic decisions could reveal insights into why Veerhealth Care's ROCE lags behind potentially and whether this is due to transient factors, or systemic issues.In conclusion, while the market assigns a high valuation to Veerhealth Care based on its PE ratio, the low ROCE raises questions about its financial stability and competitive positioning. A deeper investigation into the drivers of this ROCE, benchmarking against peers, and an assessment of future growth prospects are crucial for a comprehensive understanding. This analysis is purely observational and does not constitute investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Veerhealth Care Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of VEERHEALTH across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Conservative Debt Levels (D/E: 0.20)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
10 factors identified
Below-Average Return on Equity (1.77%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (3.14%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (1.28%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 83.22x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-16.67%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-22.72%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (-3.26% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (4.04% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Negative Free Cash Flow (₹-9.04 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Veerhealth Care Ltd Financial Statements
Comprehensive financial data for Veerhealth Care Ltd including income statement, balance sheet and cash flow
About VEERHEALTH (Veerhealth Care Ltd)
Veerhealth Care Ltd (VEERHEALTH) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹38.28 (Cr). Veerhealth Care Ltd has delivered a Return on Equity (ROE) of 1.77% and a ROCE of 3.14%. The debt-to-equity ratio stands at 0.20, reflecting the company's capital structure. Investors tracking VEERHEALTH share price can monitor key metrics including P/E ratio, promoter holding of 31.50%, and quarterly earnings growth.
Company Details
Key Leadership
Latest News
VEERHEALTH Share Price: Frequently Asked Questions
What is the current share price of Veerhealth Care Ltd (VEERHEALTH)?
As of 17 Feb 2026, 10:25 am IST, Veerhealth Care Ltd share price is ₹19.09. The VEERHEALTH stock has a market capitalisation of ₹38.28 (Cr) on NSE/BSE.
Is VEERHEALTH share price Overvalued or Undervalued?
VEERHEALTH share price is currently trading at a P/E ratio of 83.22x, compared to the industry average of 31.77x. Based on this relative valuation, the Veerhealth Care Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of VEERHEALTH share price?
The 52-week high of VEERHEALTH share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Veerhealth Care Ltd share price?
Key factors influencing VEERHEALTH share price include quarterly earnings growth (Sales Growth: -22.72%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Veerhealth Care Ltd a good stock for long-term investment?
Veerhealth Care Ltd shows a 5-year Profit Growth of 4.04% and an ROE of 1.77%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.20 before investing in VEERHEALTH shares.
How does Veerhealth Care Ltd compare with its industry peers?
Veerhealth Care Ltd competes with major peers in the Pharmaceuticals. Investors should compare VEERHEALTH share price P/E of 83.22x and ROE of 1.77% against the industry averages to determine competitive standing.
What is the P/E ratio of VEERHEALTH and what does it mean?
VEERHEALTH share price has a P/E ratio of 83.22x compared to the industry average of 31.77x. Investors pay ₹83 for every ₹1 of annual earnings.
How is VEERHEALTH performing according to Bull Run's analysis?
VEERHEALTH has a Bull Run fundamental score of 6.4/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does VEERHEALTH belong to?
VEERHEALTH operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Veerhealth Care Ltd share price.
What is Return on Equity (ROE) and why is it important for VEERHEALTH?
VEERHEALTH has an ROE of 1.77%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Veerhealth Care Ltd generates profits from shareholders capital.
How is VEERHEALTH debt-to-equity ratio and what does it indicate?
VEERHEALTH has a debt-to-equity ratio of 0.20, which indicates conservative financing with low financial risk.
What is VEERHEALTH dividend yield and is it a good dividend stock?
VEERHEALTH offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Veerhealth Care Ltd shares.
How has VEERHEALTH share price grown over the past 5 years?
VEERHEALTH has achieved 5-year growth rates of: Sales Growth 7.30%, Profit Growth 4.04%, and EPS Growth -3.26%.
What is the promoter holding in VEERHEALTH and why does it matter?
Promoters hold 31.50% of VEERHEALTH shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Veerhealth Care Ltd.
What is VEERHEALTH market capitalisation category?
VEERHEALTH has a market capitalisation of ₹38 crores, placing it in the Small-cap category.
How volatile is VEERHEALTH stock?
VEERHEALTH has a beta of N/A. A beta > 1 suggests the Veerhealth Care Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is VEERHEALTH operating profit margin trend?
VEERHEALTH has a 5-year average Operating Profit Margin (OPM) of 1.28%, indicating the company's operational efficiency.
How is VEERHEALTH quarterly performance?
Recent quarterly performance shows Veerhealth Care Ltd YoY Sales Growth of -22.72% and YoY Profit Growth of -16.67%.
What is the institutional holding pattern in VEERHEALTH?
VEERHEALTH has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Veerhealth Care Ltd stock.